Editorial Board - Journal of Pharmaceutical Sciences - Journal - Elsevier (2023)

Editorial Board - Journal of Pharmaceutical Sciences - Journal - Elsevier (1)

ISSN: 0022-3549

Journal of Pharmaceutical Sciences

Guide for authors

247 editors and editorial board members in 22 countries/regions

US

United States of America (129)

JP

Japan (35)

GB

United Kingdom (17)

IT

Italy (14)

DE

Germany (8)

AU

Australia (7)

DK

Denmark (7)

BE

Belgium (6)

SE

Sweden (5)

FI

Finland (2)

FR

France (2)

IN

India (2)

NZ

New Zealand (2)

ZA

South Africa (2)

ES

Spain (2)

BR

Brazil

CA

Canada

IS

Iceland

IE

Ireland

SG

Singapore

KR

South Korea

CH

Switzerland

Gender Diversity Distribution of the Editors

Based on 62% responding editors

0% woman100% man0% non-binary or gender diverse0% prefer not to disclose

Read more about Elsevier on the topic of diversity.

Access Elsevier’s most recent Global Gender Report.

Editor-in-Chief

  • Kenneth L. Audus

    The University of Kansas, Lawrence, Kansas, United States of America

Editors

  • Guohua An

    The University of Iowa, Iowa City, Iowa, United States of America

  • Sathy V. Balu-Iyer

    SUNY − University at Buffalo, Buffalo, New York, United States of America

  • Harry G. Brittain

    Center for Pharmaceutical Physics, Milford, New Jersey, United States of America

  • John F. Carpenter

    University of Colorado, Denver, Colorado, United States of America

  • Ferdinando Giordano

    University of Parma, Torre d’Isola (Pavia), Italy

  • Michael J. Hageman

    The University of Kansas, Lawrence, Kansas, United States of America

  • Bruno C. Hancock

    Pfizer, Inc., Groton, Connecticut, United States of America

  • Filippos Kesisoglou

    Merck & Co., Inc., West Point, Pennsylvania, United States of America

  • Hanns-Christian Mahler, Prof., Dr.

    University of Frankfurt, Frankfurt, Germany

  • Christoph Saal

    Merck KGaA, Darmstadt, Germany

  • Christian Schöneich, PhD

    The University of Kansas, Lawrence, Kansas, United States of America

  • Tetsuya Terasaki

    University of Eastern Finland School of Pharmacy, KUOPIO, Finland

Editorial Advisory Board Members

  • Anjali Agrawal

    Bristol Myers Squibb, Basking Ridge, New Jersey, United States of America

  • Shin-ichi Akanuma

    University of Toyama, Toyama, Japan

  • Hidetaka Akita

    Tohoku University Graduate School of Pharmaceutical Sciences, Faculty of Pharmaceutical Sciences, Sendai, Japan

  • Sreedhara Alavattam

    Genentech Inc, South San Francisco, California, United States of America

  • Carmen Alvarez-Lorenzo

    University of Santiago de Compostela, Santiago de Compostela, Spain

  • Fernando Alvarez-Nunez

    Amgen Inc, Thousand Oaks, California, United States of America

  • Gregory E. Amidon

    University of Michigan, Ann Arbor, Michigan, United States of America

  • Tom Anchordoquy

    University of Colorado, Aurora, Colorado, United States of America

  • Pieter Annaert

    KU Leuven, Department of Pharmaceutical and Pharmacological Sciences, Leuven, Belgium

  • Robert Arnold

    Auburn University, Auburn, Alabama, United States of America

  • Per Artursson

    Uppsala University, Uppsala, Sweden

  • Marianne Ashford

    AstraZeneca UK Limited, Macclesfield, United Kingdom

  • Patrick F. Augustijns

    Katholieke Universiteit Leuven Farmacotechnologie en Biofarmacie, Leuven, Belgium

  • Bruce J. Aungst

    AUC Sciences, Newark, Delaware, United States of America

  • Alejandro Pedro Ayala

    Federal University of Ceara, FORTALEZA, Ceará, Brazil

  • Steven Baertschi

    Baertschi Consulting LLC, Carmel, Indiana, United States of America

  • Jane Bai

    Silver Spring, Maryland, United States of America

  • Annette B. Bak

    AstraZeneca R&D Gothenburg, Göteborg, Sweden

  • Joseph P. Balthasar

    SUNY Buffalo, Buffalo, New York, United States of America

  • James G. Bann

    Wichita State University, Wichita, Kansas, United States of America

  • Arvind K. Bansal

    National Institute of Pharmaceutical Education and Research, Department of Pharmaceutics, Mohali, Punjab, India

  • Jared S. Bee

    MacroGenics Inc, Rockville, Maryland, United States of America

  • Christel Bergström

    Uppsala University, Uppsala, Sweden

  • Cory Berkland

    The University of Kansas, Lawrence, Kansas, United States of America

  • Akhilesh Bhambhani

    Merck and Co Inc West Point, Doylestown, Pennsylvania, United States of America

  • Michael Blaber

    Florida State University, Tallahassee, Florida, United States of America

  • Jeffrey T. Blue

    Merck Research Vaccines Division, West Point, Pennsylvania, United States of America

  • Joshua Siaw Boateng

    University of Greenwich, London, United Kingdom

  • Robin H. Bogner

    University of Connecticut, Storrs, Connecticut, United States of America

  • Ben Boyd

    Monash University, Clayton, Victoria, Australia

  • Birger Brodin

    University of Copenhagen, København, Denmark

  • Ira Shea Buckner

    Duquesne University, Pittsburgh, Pennsylvania, United States of America

  • James M. Butler

    GSK plc, Brentford, United Kingdom

  • Mino R. Caira

    University of Cape Town, Rondebosch, South Africa

  • Shawn Cao

    Amgen Inc, Thousand Oaks, California, United States of America

  • Carla M. Caramella

    University of Pavia, Pavia, Italy

  • Jennifer (Laurence) Chadwick

    Bioanalytix Inc, Cambridge, Maine, United States of America

  • Sayantan Chattoraj

    GSK, Philadelphia, Pennsylvania, United States of America

  • Bodhisattwa Chaudhuri

    University of Connecticut, Storrs, Connecticut, United States of America

  • Xiaodong Chen

    Bristol-Myers Squibb, New Brunswick, New York, United States of America

  • Wei Cheng

    University of Michigan, Ann Arbor, Michigan, United States of America

  • Po-Chang Chiang

    Genentech Inc, South San Francisco, California, United States of America

  • Merry Christie

    Voisin Consulting Life Sciences Cambridge, Cambridge, Massachusetts, United States of America

  • Adeola O. Coker

    University of the Incarnate Word, San Antonio, Texas, United States of America

  • Duncan Craig

    University College London School of Pharmacy, London, United Kingdom

  • Sudip Das

    Butler University, Indianapolis, Indiana, United States of America

  • Tapan K. Das

    Bristol-Myers Squibb, New Brunswick, New Jersey, United States of America

  • Rutesh Hemant Dave

    Long Island University - Brooklyn Campus, New York, New York, United States of America

  • Vivek S. Dave

    St John Fisher University, Rochester, New York, United States of America

  • Roberto DePaz

    Viela Bio, Gaithersburg, Maryland, United States of America

  • Rukman De Silva

    U.S. Food and Drug Administration, Silver Spring, Maryland, United States of America

  • Melgardt De Villiers

    University of Wisconsin-Madison, Madison, Wisconsin, United States of America

    (Video) Preparing an Article Manuscript using Elsevier Journal LaTeX Template
  • Yoshiharu Deguchi

    Teikyo University, Tokyo, Japan

  • Nunzio Denora

    University of Bari, Bari, Italy

  • James C. DiNunzio

    Merck & Co Inc, Kenilworth, New Jersey, United States of America

  • Jennifer Dressman

    Goethe University Frankfurt, Frankfurt am Main, Germany

  • Christine M. Dufes

    University of Strathclyde, Glasgow, United Kingdom

  • Carsten Ehrhardt

    The University of Dublin Trinity College, Dublin, Ireland

  • David P. Elder

    David P. Elder Consultancy, Hertford, United Kingdom

  • Reza Esfandiary

    MedImmune LLC, Gaithersburg, Maryland, United States of America

  • Frank M. Etzler

    Lake Erie College of Osteopathic Medicine School of Pharmacy, Erie, Pennsylvania, United States of America

  • David Fissore

    Politecnico di Torino, Torino, Italy

  • Camilla Foged

    University of Copenhagen, København, Denmark

  • Anastasia Foppoli

    Università degli Studi di Milano, Milano, Italy

  • Wolfgang Friess

    Ludwig Maximilians University Munich, München, Germany

  • Ryoichi Fujiwara

    University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States of America

  • John F. Gamble

    Bristol-Myers Squibb Pharmaceuticals Ltd, Uxbridge, United Kingdom

  • Sandri Giuseppina

    University of Pavia, Pavia, Italy

  • David J. Goldfarb

    Merck & Co., Inc., Rahway, New Jersey, United States of America

  • Igor Gonda

    Respidex LLC, Dennis, Massachusetts, United States of America

  • Sarah Gordon

    Liverpool John Moores University, Liverpool, United Kingdom

  • Monica Goss

    Amgen Inc, Thousand Oaks, California, United States of America

  • Henrik Green

    Linköping University, Linköping, Sweden

  • Richard Guy

    University of Bath, Department of Life Sciences, Bath, United Kingdom

  • David Harris

    Merck & Co Inc, Kenilworth, New Jersey, United States of America

  • David J. Hauss

    Regeneron Pharmaceuticals, Inc., Colts Neck, New York, United States of America

  • David Hayes

    International Solidarity of Scientists, Danbury, Connecticut, United States of America

  • Xiaorong X. He

    Boehringer-Ingelheim, Southbury, Connecticut, United States of America

  • Yan He

    Sanofi Genzyme Drug Discovery and Development, Waltham, Massachusetts, United States of America

  • Paul W. S. Heng

    National University of Singapore, Department of Pharmacy, Singapore, Singapore

  • Anothony J. Hickey

    RTI International, Research Triangle Park, North Carolina, United States of America

  • Kazutaka Higaki

    Okayama University, Okayama, Japan

  • Rene Holm

    Janssen Pharmaceutica NV, Beerse, Belgium

  • Sarah Hook

    University of Otago, Dunedin, New Zealand

  • Ken-ichi Hosoya

    University of Toyama, Toyama, Japan

  • Munir A. Hussain

    Mah Pharma Consulting LLC, Belle Mead, New Jersey, USA

  • Katsuhisa Inoue

    Tokyo University of Pharmacy and Life Science, Tokyo, Japan

  • Tatsuhiro Ishida

    University of Tokushima, Tokushima, Japan

  • Akiko Ishii-Watabe

    National Institute of Health Sciences, Kawasaki, Japan

  • Shingo Ito

    Kumamoto University, Kumamoto, Japan

  • Yasunori Iwao

    University of Shizuoka, Shizuoka, Japan

  • Ken-ichi Izutsu

    National Institute of Health Sciences, Tokyo, Japan

  • Kevin C. Johnson

    Intellipharm LLC, Niantic, Connecticut, United States of America

  • LaToya Jones Braun

    Regis University, Denver, Colorado, United States of America

  • David Jones

    Queen's University Belfast, Belfast, United Kingdom

  • Marisa K. Joubert

    Amgen Inc, Thousand Oaks, California, United States of America

  • Gerald B. Kasting

    University of Cincinnati, Cincinnati, Ohio, United States of America

  • Yukio Kato

    Kanazawa, Japan

  • Bruce A. Kerwin

    Just - Evotec Biologics Inc, Seattle, Washington, United States of America

  • Tarik Khan

    F. Hoffmann-LaRoche Ltd., Basel, Switzerland

  • Vitaliy V. Khutoryanskiy

    University of Reading, Reading, United Kingdom

  • Sandra Klein

    University of Greifswald, Greifswald, Germany

  • Peter Kleinebudde

    Heinrich Heine University Dusseldorf, Faculty of Mathematics and Natural Sciences, , Germany

  • Gregory T. Knipp

    Purdue University, West Lafayette, Indiana, United States of America

  • Kaoru Kobayashi

    Chiba University, Chiba, Japan

  • Janet G. Koe

    Corvus Pharmaceuticals Inc, Burlingame, California, United States of America

  • Mary Krause

    Bristol-Myers Squibb, New Brunswick, New Jersey, United States of America

  • Yoshiyuki Kubo

    Toyoma, Japan

  • Ozan Kumru

    The University of Kansas, Lawrence, Kansas, United States of America

  • Yurong Lai

    Gilead Sciences Inc., Foster City, California, United States of America

  • William J. Lambert

    Module 3 Pharmaceutical Consulting, Incline Village, Nevada, United States of America

  • Margaret Sue Landis

    Pfizer Global Research and Development Computational Sciences Center of Emphasis, Cambridge, Massachusetts, United States of America

  • Robert S. Langer

    Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America

  • Devalina Law

    AbbVie Inc, North Chicago, Illinois, United States of America

  • David Lechuga-Ballesteros

    AstraZeneca Pharmaceuticals LP, South San Francisco, Delaware, United States of America

  • Wooin Lee

    Seoul National University College of Medicine, Department of Pharmacology, Seoul, South Korea

  • S. Kevin Li

    University of Cincinnati, Cincinnati, Ohio, United States of America

  • Wilna Liebenberg

    North-West University, Potchefstroom, South Africa

  • Thorsteinn Loftsson

    University of Iceland, Faculty of Pharmaceutical Sciences, Reykjavik, Iceland

  • Antonio Lopalco

    University of Bari, Bari, Italy

  • Kazuya Maeda

    Kitasato University, Minato-Ku, Japan

  • Krishna Mallela

    University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States of America

  • Amedeo Marini

    University of Pavia, Pavia, Italy

  • Allexandra Maroni

    Universita degli Studi di Milano, Milano, Italy

  • Patrick J. Marsac

    University of Kentucky, Lexington, Kentucky, United States of America

  • Satohiro Masuda

    International University of Health and Welfare, Otawara, Japan

  • Michael B. Maurin

    Maurin Healthcare Consulting LLC, Wilmington, Delaware, United States of America

  • Mark McAllister

    Pfizer, Inc., Kent, United Kingdom

  • Gary McGeorge

    Bristol-Myers Squibb Co Research & Development New Brunswick, New Brunswick, New Jersey, United States of America

  • Patrick McNamara

    University of Kentucky, Lexington, Kentucky, United States of America

  • Natalie Medlicott

    University of Otago, Dunedin, New Zealand

  • Danforth Miller

    Novartis Pharmaceuticals, Burlingame, California, United States of America

  • José Ramón Moyano-Méndez

    University of Seville, Sevilla, Spain

  • Anette Müllertz

    University of Copenhagen, Faculty of Health and Medical Sciences, København, Denmark

  • Eric J. Munson

    Purdue University, West Lafayette, Indiana, United States of America

    (Video) Benefits of publishing in the European Journal of Pharmaceutical Sciences Video
  • S. Narasimha Murthy

    University of Mississippi, Department of Biomolecular Sciences Division of Pharmacology, Jackson, Mississippi, United States of America

  • Steven L. Nail

    Baxter Healthcare, West Lafayette, Indiana, United States of America

  • Miki Nakajima

    Kanazawa University, Kanazawa, Japan

  • Takeo Nakanishi

    Takasaki University of Health and Welfare, Takasaki, Japan

  • Ashwini Nangia

    University of Hyderabad, Hyderabad, India

  • Ajit S. Narang

    ORIC Pharmaceuticals, Inc., South San Francisco, California, United States of America

  • Padma Narayan

    SAGE Therapeutics, Inc., Cambridge, Massachusetts, United States of America

  • Linda O. Narhi

    Amgen Inc, Thousand Oaks, California, United States of America

  • Marino Nebuloni

    University of Parma, Parma, Italy

  • Joseph A. Nicolazzo

    Monash University, Parkville, Victoria, Australia

  • Tomohiro Nishimura

    Keio University, Minato-Ku, Japan

  • Noriko Ogawa

    Aichi Gakuin University School of Pharmacy Graduate School of Pharmacy, Nagoya, Japan

  • Takuo Ogihara

    Takasaki University of Health & Welfare, Gunma, Japan

  • Satoshi Ohtake

    Pfizer Inc Chesterfield BioTherapeutics Pharmaceutical Science, Chesterfield, Missouri, United States of America

  • Sumio Ohtsuki

    Kumamoto University, Kumamoto, Japan

  • Tomoyuki Okuda

    Meijo University, Nagoya, Japan

  • Takashi Okura

    Teikyo University, Tokyo, Japan

  • Tetsuya Ozeki

    Nagoya City University, Nagoya, Japan

  • Luka Palugan

    University of Milan, Milano, Italy

  • Jayanth Panyam

    University of Minnesota Twin Cities, Minneapolis, Minnesota, United States of America

  • Yvonne Perrie

    University of Strathclyde Institute of Pharmacy and Biomedical Sciences, Glasgow, United Kingdom

  • Christopher J. H. Porter

    Monash University, Parkville, Victoria, Australia

  • Wei Qi

    Amgen Inc, Thousand Oaks, California, United States of America

  • Thomas Rades

    Copenhagen University, København, Denmark

  • Amber Haynes Raines

    KBI Biopharma, Pickens, South Carolina, United States of America

  • Roger A. Rajewski

    The University of Kansas, Lawrence, Kansas, United States of America

  • Theodore W. Randolph

    University of Colorado Boulder, Boulder, Colorado, United States of America

  • Jukka Rantanen

    University of Copenhagen, København, Denmark

  • Susan M. Reutzel-Edens

    Eli Lilly & Company, Zionsville, Indiana, United States of America

  • Christopher Roberts

    University of Delaware, Newark, Delaware, United States of America

  • Mark C. Rogge

    Takeda Oncology, Cambridge, Massachusetts, United States of America

  • Brian R. Rohrs

    Bausch and Lomb Rochester, Rochester, New York, United States of America

  • Larry Rosen

    VenatoRx Pharmaceuticals Inc, Malvern, Pennsylvania, United States of America

  • Amy S. Rosenberg

    EpiVax, Inc., Providence, Rhode Island, United States of America

  • Alfred C. F. Rumondor

    Bristol-Myers Squibb, Raritan, New Jersey, United States of America

  • Krishnan Sampathkumar

    MacroGenics Inc, Rockville, Maryland, United States of America

  • Anna Schwendeman

    University of Michigan, Ann Arbor, Michigan, United States of America

  • Abu T. M. Serajuddin

    St John's University, Queens, New York, United States of America

  • Teruna J. Siahaan

    The University of Kansas, Lawrence, Kansas, United States of America

  • Fabio Sonvico

    University of Parma, Parma, Italy

  • Pierre O. Souillac

    Shire, Lexington, Massachusetts, United States of America

  • David Spencer

    Ipsen Biopharm Limited, Wrexham, UK

  • William C. Stagner

    Campbell University College of Pharmacy and Health Sciences, Buies Creek, North Carolina, United States of America

  • Clare Strachan

    University of Helsinki, HELSINKI, Finland

  • Robert M. Straubinger

    University at Buffalo, Buffalo, New York, United States of America

  • Robert G. Strickley

    Pliant Therapeutics, San Mateo, California, United States of America

  • Yongchao Su

    Merck & Co Inc, Kenilworth, New Jersey, United States of America

  • Changquan Calvin Sun

    University of Minnesota Twin Cities, Minneapolis, Minnesota, United States of America

  • Raj G. Suryanarayanan

    University of Minnesota Twin Cities, Minneapolis, Minnesota, United States of America

  • David R. Taft

    Long Island University - Brooklyn Campus, New York, New York, United States of America

  • Yun K. Tam

    Sinoveda Canada Inc, Edmonton, Alberta, Canada

  • Ikumi Tamai

    Kanazawa University, Kanazawa, Japan

  • Lynne S. Taylor

    Purdue University, West Lafayette, Indiana, United States of America

  • Ravindra W. Tejwani

    ACADIA Pharmaceuticals Inc, San Diego, California, United States of America

  • Allen C. Templeton

    Merck Research Laboratories, Rahway, Pennsylvania, United States of America

  • Frank-Peter Theil

    UCB Biopharma SRL, Brussels, Belgium

  • Mike Tobyn

    Bristol-Myers Squibb, Moreton, United Kingdom

  • Masatoshi Tomi

    Keio University, Minato-Ku, Japan

  • Natalie L. Trevaskis

    Monash University, Faculty of Pharmacy and Pharmaceutical Sciences, Parkville, Australia

  • Francesco Trotta

    University of Torino, Torino, Italy

  • Nicolas Tsapis

    National Centre for Scientific Research, Paris France

  • Yasuo Uchida

    Tohoku University, Sendai, Japan

  • Susumu Uchiyama

    Osaka University, Suita, Japan

  • Michiel Van Speybroeck

    Ardena Group Ltd, Gent, Belgium

  • Guy Van den Mooter

    KU Leuven, Department of Pharmaceutical and Pharmacological Sciences, Leuven, Belgium

  • Michel Vert

    University of Montpellier, Montpellier, France

  • David B. Volkin

    The University of Kansas, Lawrence, Kansas, United States of America

  • Jan L. Wahlstrom

    Amgen, Inc., Thousand Oaks, California, United States of America

  • Nicolas Warne

    Pfizer Andover, Andover, Massachusetts, United States of America

  • Marco van de Weert

    University of Copenhagen, Copenhagen, Denmark

  • Adrian C. Williams

    University of Reading, Reading, United Kingdom

  • Desmond Williams

    University of South Australia, Adelaide, Australia

  • Gerhard Winter

    LMU Munchen, Munchen, Germany

  • Qingguo Xu

    Virginia Commonwealth University, Richmond, Virginia, United States of America

  • Samuel H. Yalkowsky

    The University of Arizona College of Pharmacy, Tucson, Arizona, United States of America

  • Fumiyoshi Yamashita

    Kyoto University Graduate School of Pharmaceutical Sciences, Faculty of Pharmaceutical Sciences, Kyoto, Japan

  • Mehran Yazdanian

    Teva Pharmaceutical Industries Ltd, West Chester, Pennsylvania, United States of America

  • Kouichi Yoshinari

    University of Shizuoka, Shizuoka, Japan

  • Bi-Botti Celestin Youan

    University of Missouri Kansas City, Kansas City, Missouri, United States of America

  • Hiroaki Yuasa

    Nagoya City University, Nagoya, Japan

  • J. Axel Zeitler

    University of Cambridge, Cambridge, United Kingdom

  • Lucia Zema

    University of Milan, Milano, Italy

  • Ming Zhang

    SUNY Buffalo, Amherst, New York, United States of America

    (Video) Elsevier: Author submission process overview
  • Qi (Tony) Zhou

    Purdue University, Department of Industrial and Physical Pharmacy, West Lafayette, Indiana, United States of America

Scientific Advisors to the Editors

  • Aktham Aburub

    Eli Lilly and Company, Indianapolis, Indiana, United States of America

  • Vivek Agrahari

    CONRAD, Eastern Virginia Medical School (EVMS), Arlington, Virginia, United States of America

  • Emmanuel Akala

    Howard University, Washington, District of Columbia, United States of America

  • Ilgaz Akseli

    Bristol-Myers Squibb, Lawrenceville, New Jersey, United States of America

  • Wafa Al-Jamal

    Queen's University Belfast, Belfast, United Kingdom

  • Hassan Almoazen

    The University of Tennessee Health Science Center, Memphis, Tennessee, United States of America

  • Leah Appel

    Green Ridge Consulting, Bend, Oregon, United States of America

  • Kapildev Arora

    Pfizer Inc, New York, New York, United States of America

  • Alex Avdeef

  • John D. Ayres

    Pharma Safety Solutions, LLC, Noblesville, Indiana, United States of America

  • Ragna Berthelsen

    University of Copenhagen, København, Denmark

  • Rajni Miglani Bhardwaj

    Eli Lilly and Company, Indianapolis, Indiana, United States of America

  • Sai H.S. Boddu

    Ajman University, Ajman, United Arab Emirates

  • Vera Brinks

    ProQR Therapeutics NV, Leiden, Netherlands

  • Chad Brown

    Merck & Co Inc, Kenilworth, New Jersey, United States of America

  • Nicole Buist

    Merck & Co Inc, Kenilworth, New Jersey, United States of America

  • Ting Cai

    China Pharmaceutical University, Nanjing, China

  • Wenjin Cao

    ATARA BIOTHERAPEUTICS, Thousand Oaks, California, United States of America

  • Stephen M. Carl

    Bristol Myers Squibb Co, Princeton New Jersey, United States of America

  • Matteo Cerea

    University of Milan, Milano, Italy

  • Emel Oyku Cetin Uyanikgil

    Ege University, İzmir, Turkey

  • David Chalmers

    Monash University, Clayton, Victoria, Australia

  • Sagnik Chatterjee

    Syngene International Ltd, Bangalore, India

  • Harsh Chauhan

    Creighton University, Omaha, Nebraska, United States of America

  • Xin Chen

    GSK, Philadelphia, Pennsylvania, United States of America

  • Jason K. Cheung

    Merck & Co Inc, Kenilworth, New Jersey, United States of America

  • Yite Robert Chou

    Kite Pharma Inc, Santa Monica, California, United States of America

  • Aviva Shing Fung Chow

    The University of Hong Kong, Hong Kong, Hong Kong

  • Kwok Chow

    Covar Pharmaceuticals, Mississauga, Ontario, Canada

  • John Chung

    Amgen Inc, Thousand Oaks, California, United States of America

  • Michael DeHart

    Carolina Medical Products Co, Farmville, North Carolina, United States of America

  • Tahnee J. Dening

    The University of Kansas, Lawrence, Kansas, United States of America

  • Sathish Dharani

    Texas A&M University, College Station, Texas, United States of America

  • Nicholas Dickenson

    Utah State University, Logan, Utah, United States of America

  • Jin Dong

    Simulations Plus Inc, Lancaster, California, United States of America

  • Rohit P. Dugar

    Nutrilite Health Institute, Buena Park, California, United States of America

  • Hala M. Fadda

    Butler University, Indianapolis, Indiana, United States of America

  • Sarinj Fattah

    Royal College of Surgeons in Ireland, Dublin, Ireland

  • Shaoxin Feng

    Allergan Irvine, Irvine, California, United States of America

  • Ana Patricia Ferreira

    Bristol-Myers Squibb Pharmaceuticals Ltd Pharmaceutical Research Institute, Wirral, United Kingdom

  • Kimberly Foster

    Bristol Myers Squibb Co, Princeton, New Jersey, United States of America

  • Yuchuan Gong

    AbbVie Inc, North Chicago, Illinois, United States of America

  • Eric M. Gorman

    Gilead Sciences Inc, Foster City, California, United States of America

  • Francesca Greco

    University of Reading, Reading, United Kingdom

  • Holger Grohganz

    University of Copenhagen, København, Denmark

  • Manish Gupta

    GSK plc, Brentford, United Kingdom

  • Andrea Hawe

    Coriolis Pharma Research GmbH, Martinsried, Germany

  • Hisamitsu Hayashi

    The University of Tokyo, Bunkyo-Ku, Japan

  • David Hayes

    International Solidarity of Scientists, Danbury, Connecticut, United States of America

  • Andrea Heinz

    University of Copenhagen, København, Denmark

  • Geoffrey Hird

    Liquidia Corporation Inc, Research Triangle Park, North Carolina, United States of America

  • Yu Ishima

    University of Tokushima, Tokushima, Japan

  • Nazrul Islam

    Queensland University of Technology, Brisbane, Queensland, Australia

  • Yijia Jiang

    Coherus BioSciences Inc, Redwood City, California, United States of America

  • Liang Jin

    Monash University, Clayton, Victoria, Australia

  • Vijay Joguparthi

    Incilia Therapeutics Pvt Ltd, Hyderabad, India

  • Nate H. Joh

    Amgen Inc, Thousand Oaks, California, United States of America

  • Janan Jona

    Genentech Inc, Bagdad, Kentucky, United States of America

  • Mouhannad Jumaa

    Astura Therapeutics, San Jose, California, United States of America

  • Leonid Kagan

    Rutgers University, Department of Pharmaceutics, Piscataway, New Jersey, United States of America

  • Cavan Kalonia

    MedImmune LLC, Gaithersburg, Maryland, United States of America

  • Timothy J. Kamerzell

    HCA Midwest Health System, Kansas City, Missouri, United States of America

  • Toshiya Katsura

    Ritsumeikan University, Kyoto, Japan

  • Jeffrey Michael Katz

    AbbVie Inc, North Chicago, Illinois, United States of America

  • Janneke Keemink

    Roche UK Ltd, Welwyn Garden City, United Kingdom

  • Umesh Kestur

    Bristol-Myers Squibb Co Research & Development New Brunswick, New Brunswick, New Jersey, United States of America

  • Daniel Jon Kirby

    Aston University, Birmingham, United Kingdom

  • Klaus Knop

    Heinrich Heine University Düsseldorf, Düsseldorf, Germany

  • Lakshmi Prajanna Kolluru

    Medefil Inc, Glendale Heights, Illinois, United States of America

  • Jeffrey P. Krise

    The University of Kansas, Lawrence, Kansas, United States of America

  • Lisa A. Kueltzo

    National Institutes of Health, Bethesda, Maryland, United States of America

  • Martin Thomas Kuentz

    Muttenz, Switzerland

  • Chris Kulczar

    Merck & Co Inc, Kenilworth, New Jersey, United States of America

  • Prashant Kumar

    The University of Kansas, Lawrence, Kansas, United States of America

  • Elizabeth C. Kwong

    Kwong Eureka Solutions, Kirkland, Quebec, Canada

  • Riikka Laitinen

    University of Eastern Finland School of Pharmacy, KUOPIO, Finland

  • Yung-Chi Lee

    Merck & Co Inc, Summit, New Jersey, United States of America

  • Shui Yee Sharon Leung

    The Chinese University of Hong Kong, Hong Kong, Hong Kong

  • Feng Li

    Baylor College of Medicine, Houston, Texas, United States of America

  • Z. Jane Li

    Pharmaron Beijing Co Ltd, Beijing, China

  • Xiangmin Liao

    Himed, Old Bethpage, New York, United States of America

  • Yu-Wei Lin

    (Video) How to publish a research paper in Elsevier journal - 2020

    Monash University, Clayton, Victoria, Australia

  • Sachin Lohani

    Merck & Co Inc - Rahway, Rahway, New Jersey, United States of America

  • Enxian Lu

    Auson Pharmaceuticals, Piscataway, New Jersey, United States of America

  • Qun Lu

    Bristol-Myers Squibb, Berkley Heights, New Jersey, New Jersey, United States of America

  • Sweta Manthena

    Pfizer Inc, New York, New York, United States of America

  • Chen Mao

    Genentech Inc, South San Francisco, California, United States of America

  • William A. Marinaro

    Merck & Co Inc, Kenilworth, New Jersey, United States of America

  • Ivan Marziano

    Pfizer Global Research and Development Sandwich, Sandwich, United Kingdom

  • Takeshi Masuda

    Kumamoto University, Kumamoto, Japan

  • Roman Mathaes

    Lonza Group Ltd, Basel, Switzerland

  • Craig McKelvey

    Merck & Co Inc, Kenilworth, New Jersey, United States of America

  • Tim Menzen

    Coriolis Pharma, Martinsried, Germany

  • Saikishore Meruva

    The University of Iowa, Iowa City, Iowa, United States of America

  • Jeffrey W. Millard

    PharMolecular, LLC, Bellingham, Washington, United States of America

  • Michael Morgen

    Bend Research Inc., Bend, Oregon, United States of America

  • John Morrison

    Bristol-Myers Squibb, Lawrenceville, New Jersey, United States of America

  • Qingxin Mu

    University of Washington, Seattle, Washington, United States of America

  • Karthik Nagapudi

    Genentech Inc, South San Francisco, California, United States of America

  • Seshadri Neervannan

    Allergan Irvine, Irvine, California, United States of America

  • Haichen Nie

    Teva Pharmaceutical Industries Ltd, West Chester, Pennsylvania, United States of America

  • Saki Noguchi

    Keio University, Minato-Ku, Japan

  • Defang Ouyang

    University of Macau, Taipa, Macao

  • Gautam Pangu

    Merck Sharp & Dohme UK Ltd, London, United Kingdom

  • Yijun Pangu

    Monash University, Clayton, Victoria, Australia

  • James Patterson

    GlaxoSmithKline Australia Pty Ltd Abbotsford Office, Abbotsford, Australia

  • Bhushan S. Pattni

    PureTech Health, Boston, Massachusetts, United States of America

  • Amrit Paudel

    Graz University of Technology, Graz, Austria

  • Shubhajit Paul

    Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, Connecticut, United States of America

  • Sathyanarayana R. Perumalla

    Seven Star Pharmaceutical Services, Wilmington, Delaware, United States of America

  • Adam Todd Procopio

    Merck & Co Inc, Kenilworth, New Jersey, United States of America

  • Chetan Pujara

    Allergan Irvine, Irvine, California, United States of America

  • Radha Ramakrishnan

    Bristol-Myers Squibb, Lawrenceville, New Jersey, United States of America

  • Yingqing Ran

    Genentech Inc, South San Francisco, California, United States of America

  • Jarkko Rautio

    University of Eastern Finland School of Pharmacy, KUOPIO, Finland

  • Gregory A. Sacha

    Baxter Healthcare Corp Round Lake, Round Lake, Illinois, United States of America

  • Hideyuki Saito

    Kumamoto University Hospital, Kumamoto, Japan

  • Atul Saluja

    Bristol-Myers Squibb, Framingham, Massachusetts, United States of America

  • Bipul Sarma

    Department of Chemical Sciences, Tezpur University, Tezpur, India

  • Stephan Schmidt

    University of Florida College of Pharmacy, Gainesville, Florida, United States of America

  • Jay A. Schrier

    Bioserv Corporation, San Diego, California, United States of America

  • Christian Seiler

    ViiV Healthcare, Brentford, United Kingdom

  • John G. Sheehan

    Merck Animal Health Rahway, Rahway, New Jersey, United States of America

  • Ahmad Y. Sheikh

    AbbVie Inc, North Chicago, Illinois, United States of America

  • Jie Shen

    University of Rhode Island College of Pharmacy, Kingston, Rhode Island, United States of America

  • Limin Shi

    Upsher-Smith Laboratories Inc, Maple Grove, Minnesota, United States of America

  • Roman Shimanovich

    Amgen Inc, Thousand Oaks, California, United States of America

  • Rok Sibanc

    Bayer AG, Leverkusen, Germany

  • Jürgen Siepmann

    University of Lille, Faculty of Pharmacy, Lille cedex, France

  • Dmitri Simberg

    University of Colorado Cancer Center, Aurora, Colorado, United States of America

  • Nataša Škalko-Basnet

    UiT The Arctic University of Norway, Tromsø, Norway

  • William Smith

    Merck and Co Inc West Point, West Point, Pennsylvania, United States of America

  • Phillip Snyder

    Vertex Pharmaceuticals Incorporated, Boston, Massachusetts, United States of America

  • Im-Sook Song

    Kyungpook National University, Daegu, South Korea

  • Alejandro Sosnik

    Technion Israel Institute of Technology, Haifa, Israel

  • Tappei Takada

    The University of Tokyo Hospital, Bunkyo-Ku, Japan

  • Yuma Tega

    Teikyo University, Itabashi-Ku, Japan

  • Tomohiro Terada

    Shiga University of Medical Science Hospital Pharmacy, Otsu, Shiga Prefecture, Japan

  • Marc Tesconi

    Pfizer Global Research and Development, Groton, Connecticut, United States of America

  • David S. Thiriot

    Merck & Co Inc, Kenilworth, New Jersey, United States of America

  • Prajwal G. Thool

    Bristol-Myers Squibb, Lawrenceville, New Jersey, United States of America

  • Ruhi Ubale

    Grail LLC, Redwood City, California, United States of America

  • Carlo Vecchio

    Pharmaceutical Technologies, Revislate, Italy

  • Maria Vertzoni

    National and Kapodistrian University of Athens, Athens, Greece

  • Valvanera Vozmediano

    University of Central Florida, Orlando, Florida, United States of America

  • Matthias Wacker

    Fraunhofer Institute for Molecular Biology and Applied Ecology IME, Aachen, Germany

  • Paul Walsh

    Merck & Co Inc, Kenilworth, New Jersey, United States of America

  • Chenguang Wang

    University of Minnesota Twin Cities, Minneapolis, Minnesota, United States of America

  • Michael Zhuo Wang

    The University of Kansas, Lawrence, Kansas, United States of America

  • Baojian Wu

    Guangzhou University of Chinese Medicine, Guangzhou, China

  • Ke Wu

    Allergan Irvine, Irvine, California, United States of America

  • Tian Wu

    Amgen Inc, Thousand Oaks, California, United States of America

  • Long Xu

    Janssen Pharmaceuticals Research and Development Center Shanghai, Shanghai, China

  • Yan Xu

    Janssen Research and Development Spring House, Spring House, Pennsylvania, China

  • Rajbharan Yadav

    Genentech Inc, South San Francisco, California, United States of America

  • Yoon Yeo

    Purdue University, Department of Industrial and Physical Pharmacy, West Lafayette, Indiana, United States of America

  • Shawn. X. Yin

    Bristol-Myers Squibb Co Research & Development New Brunswick, New Brunswick, New Jersey, United States of America

  • Etsuo Yonemochi

    Hoshi University Graduate School of Pharmaceutical Sciences, Shinagawa-Ku, Japan

  • Xiaoda Yuan

    Allergan Irvine, Irvine, California, United States of America

  • Li Zhang

    Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America

  • Xinyuan Zhang

  • Xiaobin (Ben) Zhao

    The WhiteOak Group LLC, Washington, District of Columbia, United States of America

  • Deliang Zhou

    AbbVie Inc, North Chicago, Illinois, United States of America

  • Lei Zhu

    Merck & Co Inc, Kenilworth, New Jersey, United States of America

Editor Emeritus

  • Ronald T. Borchardt

    The University of Kansas, Lawrence, United States of America

    (Video) Publication Houses of Pharmacy /Medical Journals

All members of the Editorial Board have identified their affiliated institutions or organizations, along with the corresponding country or geographic region. Elsevier remains neutral with regard to any jurisdictional claims.

FAQs

Is Journal of Pharmaceutical Sciences q1 or Q2? ›

Journal of Pharmaceutical Sciences Q2.

Is IJPR a good journal? ›

The International Journal of Production Research (IJPR), published since 1961, is a well-established, highly successful and leading journal reporting manufacturing, production and operations management research.

Is IJPR Scopus indexed? ›

The journal is well indexed with Scopus, EMBASE- Elsevier's, PubMed (Selected citations), Thomson Reuters, Web of Science – Emerging Sources Citation Index (Jan 2021), Hinari- WHO, Chemical Abstract, Scirus – Elsevier's, Gale- Expanded Academic ASAP, EBSCO, Google, Google Scholar, International consortium for the ...

Who is the editor in chief of Journal of Pharmaceutical Sciences? ›

New Editor-in-Chief Dr. Ken Audus - Announcements - Journal of Pharmaceutical Sciences - Journal - Elsevier.

Is Elsevier a Q1 journal? ›

There are a total of 1460 Elsevier Q1 journals in 2023. The top 60 Q1 Elsevier journals are listed in this blog post. However, the researchers can download the complete list of Elsevier Q1 journals from the official website of Scopus.

How do I know if I have Q1 or Q2 journal? ›

Each subject category of journals is divided into four quartiles: Q1, Q2, Q3, Q4. Q1 is occupied by the top 25% of journals in the list; Q2 is occupied by journals in the 25 to 50% group; Q3 is occupied by journals in the 50 to 75% group and Q4 is occupied by journals in the 75 to 100% group.

How do you know if a journal is predatory? ›

6 Ways to Spot a Predatory Journal
  1. Always check the website thoroughly. ...
  2. Check if the journal is a member of DOAJ, COPE, OASPA or STM. ...
  3. Check the journal's contact information. ...
  4. Research the editorial board. ...
  5. Take a look at their peer review process and publication timelines. ...
  6. Read through past issues of the journal.

What is a Tier 1 journal? ›

Tier 1. High category (3.5-4) Peer-reviewed publications in one of the following: • Journal with Impact factor that falls in the top 25 percentile ranking based on the impact. factor within the subject, discipline, or sub-disciplinary category (refer to APPENDIX.

What is the most respected journal? ›

List of Top 100 Journals with Highest Impact Factor
  • Nature – Impact Factor: 42.78. ...
  • The New England Journal of Medicine – Impact Factor: 74.7. ...
  • Science – Impact Factor: 41.84. ...
  • IEEE/CVF Conference on Computer Vision and Pattern Recognition – Impact Factor: 45.17. ...
  • The Lancet – Impact Factor: 59.1.

Are all Elsevier journals Scopus indexed? ›

As per our agreement with Elsevier (Scopus is an Elsevier product), signed in February 2022, all books published from January 2021 will be indexed.

How do you know if a journal is Scopus or SCI indexed? ›

How to Identify SCOPUS Indexed Journals?
  1. Type the URL in your address bar:
  2. www.SCOPUS.com/sources.
  3. It will direct into Browse sources on SCOPUS.com – Journal List search page to identify SCOPUS indexed journals.
  4. Select the Title, Publisher, or ISSN number of the targeted journal to find SCOPUS indexing.
Apr 20, 2021

Why journals are discontinued from Scopus? ›

The journals included in Scopus are periodically re-evaluated to ensure they meet indexing criteria and some journals might be discontinued for 'publication concerns'. Previously published articles may remain indexed and can be cited.

Who owns the pharmaceutical journal? ›

The Pharmaceutical Journal is published by the Pharmaceutical Press, a wholly owned subsidiary of the Royal Pharmaceutical Society and is recognised as an editorially independent publication under the terms of the Royal Pharmaceutical Society's charter.

What is the impact factor of Journal of Pharmaceutical Sciences? ›

The 2022-2023 Journal's Impact IF of Journal of Pharmaceutical Sciences is 3.534, which is just updated in 2023.

Is the Journal of Pharmaceutical Sciences peer-reviewed? ›

JPharmSci®'s Editorial Team is pleased to publicly recognize and thank the Top Reviewers who have made particularly significant contributions to the journal's peer review process in 2022.

Is Elsevier a top journal? ›

3. What is Elsevier journal's ranking? According to the Scilit ranking, Elsevier is ranked first among publishers by the number of articles published and second among publishers by the number of open access articles published.

What is the impact factor for Elsevier journals? ›

The journal's impact factor has risen each year, from 1.82 in 2014 to 8.890 in 2021; the 5-year impact factor is 9.620.

Are any Elsevier journals predatory? ›

Scientific and academic publisher Reed Elsevier released six journals that were found to feature falsified peer reviews. These peer reviews were paid for by pharmaceutical companies, including pharma giant Merck. Elsevier has also been involved in other scandals, including being accused of publishing racist content.

Which is the Q1 journal for pharmaceutical sciences? ›

International Journal of Pharmaceutics is a journal covering the categories related to Pharmaceutical Science (Q1). It is published by Elsevier. The overall rank of International Journal of Pharmaceutics is 4118. ISSN of this journal is/are 18733476, 03785173.

Which Mdpi journals are Q1? ›

JournalImpact FactorRank
Nutrients6.706Q1
Cancers6.575Q1
Pharmaceutics6.525Q1
International Journal of Molecular Sciences6.208Q1
133 more rows
Jun 28, 2022

What is a Q1 ranked journal? ›

Q1 is shorthand for the "first quartile" or the top 25% of a subject area. These ratings are updated yearly and usually run on a three or four year cycle (i.e. they rate journals based on their performance over the last three or four years).

Is Pccp a Q1 journal? ›

This journal has an h-index of 256. The best quartile for this journal is Q1. The ISSN of Physical Chemistry Chemical Physics journal is 14639084, 14639076.

Which is better Q1 or Q4 journal? ›

Q1 is occupied by the top 25% of journals in the list; Q2 is occupied by journals in the 25 to 50% group; Q3 is occupied by journals in the 50 to 75% group and Q4 is occupied by journals in the 75 to 100% group. The most prestigious journals within a subject area are those which occupy the first quartile, Q1.

What is Q1 Q2 Q3 Pharma? ›

Q1: Same components. – Q2: Same components in same concentration. – Q3: Same components in same concentration with. the same arrangement of matter (microstructure) • Q3 is characterization based determination.

What is the ranking of Journal of Pharmaceutical Sciences? ›

The overall rank of Journal of Pharmaceutical Sciences is 7877. According to SCImago Journal Rank (SJR), this journal is ranked 0.625.

Is it difficult to publish in MDPI? ›

MDPI has one of the most straightforward and efficient publication processes in the whole publishing landscape. Most of our journals suggest 5 days for minor revisions and 10–14 days for major revisions.

Is it good to publish in MDPI journal? ›

The quality of the papers published in MDPI Special Issues is very high! I had a great experience with MDPI (Energies Journal) when publishing my research work. The manuscript submission process and the speed of publication were outstanding.

Which MDPI journal has the highest impact factor? ›

Top Ranking MDPI Journals
  • Antioxidants. Antioxidants leads the way with an excellent Impact Factor of 7.675. ...
  • Cells. Cells follows closely behind with an Impact Factor of 7.666. ...
  • Nutrients. Nutrients also has a fantastic Impact Factor of 6.706. ...
  • Cancers. ...
  • Pharmaceutics.
Jul 12, 2022

Videos

1. Reporting in Editorial Manager: Assignment Status Report
(Elsevier Editorial Manager Training)
2. Find the journal of Wiley, IEEE, Elsevier, Springer for your Research Paper for high acceptance rate
(mgaricent)
3. How to submit research articles to Elsevier journal - 2020 - Elsevier Paper Submission Tutorials
(CVSRP RESEARCH)
4. Free list of Elsevier journals with no publication fees. No article publication fees, NO APC
(PhDians)
5. Elsevier: Article Transfer Service (ATS) author overview
(Elsevier Editorial Manager Training)
6. How to find latest Impact Factor of a journal? Best way to find out impact factor of an article?
(XploreBio)
Top Articles
Latest Posts
Article information

Author: Dean Jakubowski Ret

Last Updated: 27/04/2023

Views: 5509

Rating: 5 / 5 (70 voted)

Reviews: 93% of readers found this page helpful

Author information

Name: Dean Jakubowski Ret

Birthday: 1996-05-10

Address: Apt. 425 4346 Santiago Islands, Shariside, AK 38830-1874

Phone: +96313309894162

Job: Legacy Sales Designer

Hobby: Baseball, Wood carving, Candle making, Jigsaw puzzles, Lacemaking, Parkour, Drawing

Introduction: My name is Dean Jakubowski Ret, I am a enthusiastic, friendly, homely, handsome, zealous, brainy, elegant person who loves writing and wants to share my knowledge and understanding with you.